Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]
EJC Skin Cancer · 2026-03 · 100783
DOI: 10.1016/j.ejcskn.2026.100783 ↗Kurz gefasst
Fachartikel in der Zeitschrift EJC Skin Cancer, 2026-03. Verfasst von Adielle Abecassis und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abecassis, A., Perray, L., Molinier, R., Idoudi, S., Kemp, H., Lebbé, C., Vercellino, L., Ezine, E., & Fournier, M. (2026). Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]. EJC Skin Cancer, 100783. https://doi.org/10.1016/j.ejcskn.2026.100783
Vancouver
Abecassis A, Perray L, Molinier R, Idoudi S, Kemp H, Lebbé C, et al. Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]. EJC Skin Cancer. 2026:100783. doi:10.1016/j.ejcskn.2026.100783
BibTeX
@article{Abecassis2026,
author = {Abecassis, Adielle and Perray, Laura and Molinier, Rafaele and Idoudi, Safa and Kemp, Helene and Lebbé, Céleste and Vercellino, Laetitia and Ezine, Emilien and Fournier, Marie},
title = {Erratum to: Exceptional case of tumor lysis syndrome following Encorafénib-Binimétinib therapy for metastatic melanoma journal: EJC skin cancer [Vol. 4, 2026, 100775]},
journal = {EJC Skin Cancer},
year = {2026},
pages = {100783},
doi = {10.1016/j.ejcskn.2026.100783}
}
EUVIMED